BNP Paribas Financial Markets Sells 195,733 Shares of Xylem Inc. $XYL

BNP Paribas Financial Markets trimmed its holdings in shares of Xylem Inc. (NYSE:XYLFree Report) by 41.5% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 275,549 shares of the industrial products company’s stock after selling 195,733 shares during the period. BNP Paribas Financial Markets’ holdings in Xylem were worth $37,524,000 at the end of the most recent reporting period.

Other large investors have also recently modified their holdings of the company. Knuff & Co LLC purchased a new stake in Xylem during the 3rd quarter valued at about $27,000. Wexford Capital LP bought a new position in Xylem during the 3rd quarter worth approximately $27,000. Board of the Pension Protection Fund purchased a new position in Xylem in the 4th quarter worth approximately $27,000. Ramirez Asset Management Inc. lifted its position in Xylem by 100.0% in the third quarter. Ramirez Asset Management Inc. now owns 200 shares of the industrial products company’s stock valued at $30,000 after purchasing an additional 100 shares during the last quarter. Finally, FWL Investment Management LLC purchased a new stake in shares of Xylem during the second quarter valued at approximately $43,000. Hedge funds and other institutional investors own 87.96% of the company’s stock.

Analyst Ratings Changes

XYL has been the topic of several recent analyst reports. Citigroup cut their target price on shares of Xylem from $174.00 to $168.00 and set a “buy” rating on the stock in a report on Wednesday, April 29th. Barclays cut their target price on shares of Xylem from $156.00 to $154.00 and set an “overweight” rating on the stock in a report on Wednesday, April 29th. Robert W. Baird set a $161.00 target price on shares of Xylem in a report on Wednesday, February 11th. Mizuho set a $138.00 target price on shares of Xylem in a report on Wednesday, February 11th. Finally, Oppenheimer cut their target price on shares of Xylem from $160.00 to $158.00 and set an “outperform” rating on the stock in a report on Wednesday, April 29th. Seven analysts have rated the stock with a Buy rating and six have issued a Hold rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $152.77.

Get Our Latest Report on XYL

Insider Buying and Selling at Xylem

In related news, CAO Geri-Michelle Mcshane sold 4,269 shares of Xylem stock in a transaction on Thursday, May 7th. The shares were sold at an average price of $117.46, for a total value of $501,436.74. Following the sale, the chief accounting officer owned 3,605 shares in the company, valued at $423,443.30. The trade was a 54.22% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, Director Jerome A. Peribere purchased 1,210 shares of the business’s stock in a transaction that occurred on Monday, May 4th. The stock was bought at an average price of $116.61 per share, for a total transaction of $141,098.10. Following the acquisition, the director owned 27,209 shares of the company’s stock, valued at $3,172,841.49. This represents a 4.65% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. Insiders own 0.32% of the company’s stock.

Xylem Stock Down 0.4%

Shares of Xylem stock opened at $109.88 on Thursday. The company has a debt-to-equity ratio of 0.13, a quick ratio of 1.10 and a current ratio of 1.46. Xylem Inc. has a 52-week low of $105.29 and a 52-week high of $154.27. The stock has a market capitalization of $26.12 billion, a price-to-earnings ratio of 27.33, a P/E/G ratio of 1.57 and a beta of 1.04. The company’s 50 day moving average price is $117.20 and its 200-day moving average price is $128.77.

Xylem (NYSE:XYLGet Free Report) last released its quarterly earnings results on Tuesday, April 28th. The industrial products company reported $1.12 earnings per share for the quarter, beating the consensus estimate of $1.09 by $0.03. The business had revenue of $2.13 billion for the quarter, compared to analysts’ expectations of $2.11 billion. Xylem had a net margin of 10.79% and a return on equity of 11.26%. The firm’s revenue for the quarter was up 2.7% compared to the same quarter last year. During the same quarter in the previous year, the business posted $1.03 earnings per share. Xylem has set its FY 2026 guidance at 5.350-5.600 EPS. Equities research analysts forecast that Xylem Inc. will post 5.51 EPS for the current year.

Xylem Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Thursday, June 25th. Investors of record on Thursday, May 28th will be issued a $0.43 dividend. The ex-dividend date is Thursday, May 28th. This represents a $1.72 annualized dividend and a yield of 1.6%. Xylem’s payout ratio is 42.79%.

Xylem announced that its board has authorized a stock repurchase plan on Wednesday, February 25th that authorizes the company to repurchase $1.50 billion in outstanding shares. This repurchase authorization authorizes the industrial products company to buy up to 4.8% of its stock through open market purchases. Stock repurchase plans are typically an indication that the company’s leadership believes its stock is undervalued.

Xylem Profile

(Free Report)

Xylem Inc (NYSE: XYL) is a global water technology company that designs, manufactures and services engineered systems and equipment for the transport, treatment, testing and efficient use of water. Its product portfolio spans pumps and pumping systems, valves, filtration and disinfection equipment, sensors and analytical instruments, and digital solutions for monitoring and control of water infrastructure. Xylem serves the full water cycle with offerings for water and wastewater utilities, industrial customers, commercial and residential buildings, and agricultural applications.

The company was established as an independent publicly traded company in 2011 following a corporate spin-off from ITT Corporation and is headquartered in Rye Brook, New York.

Featured Articles

Want to see what other hedge funds are holding XYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Xylem Inc. (NYSE:XYLFree Report).

Institutional Ownership by Quarter for Xylem (NYSE:XYL)

Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.